British Journal of Cancer - Table of Contents alert Volume 118 Issue 7

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 118, Issue 7 In this issue Editorial Article Correspondence Also new AOP   Editorial From checkpoint to checkpoint: DNA damage ATR/Chk1 checkpoint signalling elicits PD-L1 immune checkpoint activation Kent W. Mouw & Panagiotis A. Konstantinopoulos British Journal of Cancer 2018 118 :933 - 935; March 13, 2018; 10.1038/s41416-018-0017-x   Abstract | Full Text New opportunities for kinase drug repurposing and target discovery Stefan Knapp British Journal of Cancer 2018 118 :936 - 937; March 16, 2018; 10.1038/s41416-018-0045-6   Abstract | Full Text Article A phase 1 dose-escalation study of veliparib with bimonthly FOLFIRI in patients with advanced solid tumours Jordan Berlin, Ramesh K. Ramanathan, John H. Strickler, Deepa S. Subramaniam, John Marshall et al. British Journal of Cancer 2018 118 :938 - 946; March 12, 2018; 10.1038/s41416-018-0003-3   Abstract | Full Text Expression of dihydropyrimidine dehydrogenase (DPD) and hENT1 predicts survival in pancreatic cancer N. O. Elander, K. Aughton, P. Ghaneh, J. P. Neoptolemos, D. H. Palmer et al. British Journal of Cancer 2018 118 :947 - 954; March 08, 2018; 10.1038/s41416-018-0004-2   Abstract | Full Text Differential histopathologic parameters in colorectal cancer liver metastases resected after triplets plus bevacizumab or cetuximab: a pooled analysis of five prospective trials Chiara Cremolini, Massimo Milione, Federica Marmorino, Federica Morano, Gemma Zucchelli et al. British Journal of Cancer 2018 118 :955 - 965; March 13, 2018; 10.1038/s41416-018-0015-z   Abstract | Full Text Phase II study of everolimus (RAD001) monotherapy as first-line treatment in advanced biliary tract cancer with biomarker exploration: the RADiChol Study David K. Lau, Rebecca Y. Tay, Yvonne H. Yeung, Fiona Chionh, Jennifer Mooi et al. British Journal of Cancer 2018 118 :966 - 971; March 12, 2018; 10.1038/s41416-018-0021-1   Abstract | Full Text Identification of selective inhibitors for diffuse-type gastric cancer cells by screening of annotated compounds in preclinical models Shu Shimada, Yoshimitsu Akiyama, Kaoru Mogushi, Mari Ishigami-Yuasa, Hiroyuki Kagechika et al. British Journal of Cancer 2018 118 :972 - 984; March 12, 2018; 10.1038/s41416-018-0008-y   Abstract | Full Text AKR1C enzymes sustain therapy resistance in paediatric T-ALL Roberta Bortolozzi, Silvia Bresolin, Elena Rampazzo, Maddalena Paganin, Francesca Maule et al. British Journal of Cancer 2018 118 :985 - 994; March 08, 2018; 10.1038/s41416-018-0014-0   Abstract | Full Text Mapping of the three-dimensional lymphatic microvasculature in bladder tumours using light-sheet microscopy Nobuyuki Tanaka, Dagmara Kaczynska, Shigeaki Kanatani, Cecilia Sahlgren, Przemyslaw Mitura et al. British Journal of Cancer 2018 118 :995 - 999; March 08, 2018; 10.1038/s41416-018-0016-y   Abstract | Full Text Pre-B acute lymphoblastic leukaemia recurrent fusion, EP300-ZNF384, is associated with a distinct gene expression Barbara J. McClure, Susan L. Heatley, Chung H Kok, Teresa Sadras, Jiyuan An et al. British Journal of Cancer 2018 118 :1000 - 1004; March 13, 2018; 10.1038/s41416-018-0022-0   Abstract | Full Text Tobacco, alcohol use and risk of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: The Liver Cancer Pooling Project Jessica L. Petrick, Peter T. Campbell, Jill Koshiol, Jake E. Thistle, Gabriella Andreotti et al. British Journal of Cancer 2018 118 :1005 - 1012; March 09, 2018; 10.1038/s41416-018-0007-z   Abstract | Full Text Body mass index throughout adulthood, physical activity, and risk of multiple myeloma: a prospective analysis in three large cohorts Catherine R. Marinac, Brenda M. Birmann, I-Min Lee, Bernard A. Rosner, Mary K. Townsend et al. British Journal of Cancer 2018 118 :1013 - 1019; March 12, 2018; 10.1038/s41416-018-0010-4   Abstract | Full Text Influence of obesity-related risk factors in the aetiology of glioma Linden Disney-Hogg, Amit Sud, Philip J. Law, Alex J. Cornish, Ben Kinnersley et al. British Journal of Cancer 2018 118 :1020 - 1027; March 13, 2018; 10.1038/s41416-018-0009-x   Abstract | Full Text Correspondence Comment on 'MicroRNA-199b-5p attenuates TGF-ß1-induced epithelial–mesenchymal transition in hepatocellular carcinoma' Ion Cristóbal, Andrea Santos, Silvia González, Melania Luque, Blanca Torrejón et al. British Journal of Cancer 2018 118 :1028 - 1029; March 19, 2018; 10.1038/s41416-018-0013-1   Abstract | Full Text Reply to 'Comment on 'MicroRNA-199b-5p attenuates TGF-ß1-induced epithelial-mesenchymal transition in hepatocellular carcinoma'' Shao-jun Zhou, Fu-yao Liu, Yuan-hui Jiang & Hui-fang Liang British Journal of Cancer 2018 118 :1030 - 1030; March 19, 2018; 10.1038/s41416-018-0031-z   Abstract | Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2018 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.